Is a master’s in public health (MPH) degree worth it?
Fortune· 2 weeks agoTo propel her career ambitions, Carrington enrolled in the online master’s degree program in public...
What career opportunities are available to someone with a master's of public health?
Fortune· 2 weeks agoAccording to one study, the number of public health degrees awarded swelled by more than 300% from...
This program pays new grads a big tech salary to work at nonprofits
Fast Company Magazine· 3 days agoWhen Chase Thomas graduated from Cornell with a concentration indata science, he could have gotten a...
Business owners: Google is offering to pay for your employees data and business education training
Fortune· 4 days ago“It’s no secret that businesses of all sizes are struggling to hire and retain talent with key...
How long does it take to earn an online master’s degree in public health?
Fortune· 2 weeks agoThe time it takes you to earn an online master’s degree in public health (MPH) will vary, but the...
Op-Ed: California's math education needs an update, but not the one proposed
Los Angeles Times Opinion via Yahoo News· 4 days agoThe last math curriculum framework was adopted in 2013. Now the latest effort to rewrite the...
Exclusive: How Heidi O’Neill Rose to Become Nike’s Most Powerful Woman Overseeing $40B in Annual...
Footwear News via Yahoo News· 6 hours agoHow do you plan demand when we don’t know if people will leave their homes and that changes over...
Digital Divide: Data Portal Highlights Internet Inequities in Chicago
SciTechDaily· 7 days agoIn an effort to reduce disparities, the University of Chicago Data Science Institute launches a data...
GMAT vs GRE: here’s what MBA applicants need to know heading into 2023
Fortune· 6 days agoA lot goes into putting together a strong application for an MBAprogram: recommendation letters,...
Vyant Bio Announces Participation in BioNJ’s 12th Annual BioPartnering Conference
Morningstar· 2 weeks agoCHERRY HILL, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders, announced that